Solid Biosciences Cash from Investing (Quarterly) Analysis

Solid Biosciences Inc (SLDB)

8.94 -0.36 (-3.87%) USD | NASDAQ | May 17, 16:00

8.94 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	-38.49M
December 31, 2023	45.30M
September 30, 2023	-24.64M
June 30, 2023	-48.23M
March 31, 2023	37.26M
December 31, 2022	66.10M
September 30, 2022	14.91M
June 30, 2022	-59.60M
March 31, 2022	37.74M
December 31, 2021	30.18M
September 30, 2021	-72.51M
June 30, 2021	-48.72M
March 31, 2021	-0.035M
December 31, 2020	-0.06M
September 30, 2020	-0.08M

Date	Value
June 30, 2020	0.322M
March 31, 2020	6.418M
December 31, 2019	2.855M
September 30, 2019	3.963M
June 30, 2019	24.14M
March 31, 2019	-6.445M
December 31, 2018	-21.26M
September 30, 2018	-1.397M
June 30, 2018	-2.49M
March 31, 2018	-1.611M
December 31, 2017	-2.809M
September 30, 2017	-7.316M
June 30, 2017	13.61M
March 31, 2017	6.962M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-72.51M

Minimum

Sep 2021

66.10M

Maximum

Dec 2022

-1.158M

Average

1.588M

Median

Cash from Investing (Quarterly) Benchmarks

Sarepta Therapeutics Inc	218.80M
PTC Therapeutics Inc	-114.93M
Capricor Therapeutics Inc	-9.502M
Catalyst Pharmaceuticals Inc	-0.199M
Pfizer Inc	1.732B

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-25.19M
Cash from Financing (Quarterly)	107.24M
Free Cash Flow	-92.54M
Free Cash Flow Per Share (Quarterly)	-0.6642
Free Cash Flow Yield	-42.15%